Cargando…
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHO...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596937/ https://www.ncbi.nlm.nih.gov/pubmed/34789319 http://dx.doi.org/10.1186/s13148-021-01196-1 |
_version_ | 1784600500495187968 |
---|---|
author | Manoochehri, Mehdi Hielscher, Thomas Borhani, Nasim Gerhäuser, Clarissa Fletcher, Olivia Swerdlow, Anthony J. Ko, Yon-Dschun Brauch, Hiltrud Brüning, Thomas Hamann, Ute |
author_facet | Manoochehri, Mehdi Hielscher, Thomas Borhani, Nasim Gerhäuser, Clarissa Fletcher, Olivia Swerdlow, Anthony J. Ko, Yon-Dschun Brauch, Hiltrud Brüning, Thomas Hamann, Ute |
author_sort | Manoochehri, Mehdi |
collection | PubMed |
description | BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHODS: Leukocyte subtype-specific unmethylated/methylated CpG sites were selected, and methylation levels at these sites were used as proxies for immune cell type proportions and mdNLR estimation in 231 TNBC cases and 231 age-matched controls. Data were validated using the Houseman deconvolution method. Additionally, the natural killer (NK) cell ratio was measured in a prospective sample set of 146 TNBC cases and 146 age-matched controls. RESULTS: The mdNLRs were higher in TNBC cases compared with controls and associated with TNBC (odds ratio (OR) range (2.66–4.29), all P(adj.) < 1e−04). A higher neutrophil ratio and lower ratios of NK cells, CD4 + T cells, CD8 + T cells, monocytes, and B cells were associated with TNBC. The strongest association was observed with decreased NK cell ratio (OR range (1.28–1.42), all P(adj.) < 1e−04). The NK cell ratio was also significantly lower in pre-diagnostic samples of TNBC cases compared with controls (P = 0.019). CONCLUSION: This immunomethylomic study shows that a shift in the ratios/proportions of leukocyte subtypes is associated with TNBC, with decreased NK cell showing the strongest association. These findings improve our knowledge of the role of the immune system in TNBC and point to the possibility of using NK cell level as a non-invasive molecular marker for TNBC risk assessment, early detection, and prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01196-1. |
format | Online Article Text |
id | pubmed-8596937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85969372021-11-17 Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients Manoochehri, Mehdi Hielscher, Thomas Borhani, Nasim Gerhäuser, Clarissa Fletcher, Olivia Swerdlow, Anthony J. Ko, Yon-Dschun Brauch, Hiltrud Brüning, Thomas Hamann, Ute Clin Epigenetics Research BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHODS: Leukocyte subtype-specific unmethylated/methylated CpG sites were selected, and methylation levels at these sites were used as proxies for immune cell type proportions and mdNLR estimation in 231 TNBC cases and 231 age-matched controls. Data were validated using the Houseman deconvolution method. Additionally, the natural killer (NK) cell ratio was measured in a prospective sample set of 146 TNBC cases and 146 age-matched controls. RESULTS: The mdNLRs were higher in TNBC cases compared with controls and associated with TNBC (odds ratio (OR) range (2.66–4.29), all P(adj.) < 1e−04). A higher neutrophil ratio and lower ratios of NK cells, CD4 + T cells, CD8 + T cells, monocytes, and B cells were associated with TNBC. The strongest association was observed with decreased NK cell ratio (OR range (1.28–1.42), all P(adj.) < 1e−04). The NK cell ratio was also significantly lower in pre-diagnostic samples of TNBC cases compared with controls (P = 0.019). CONCLUSION: This immunomethylomic study shows that a shift in the ratios/proportions of leukocyte subtypes is associated with TNBC, with decreased NK cell showing the strongest association. These findings improve our knowledge of the role of the immune system in TNBC and point to the possibility of using NK cell level as a non-invasive molecular marker for TNBC risk assessment, early detection, and prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01196-1. BioMed Central 2021-11-17 /pmc/articles/PMC8596937/ /pubmed/34789319 http://dx.doi.org/10.1186/s13148-021-01196-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Manoochehri, Mehdi Hielscher, Thomas Borhani, Nasim Gerhäuser, Clarissa Fletcher, Olivia Swerdlow, Anthony J. Ko, Yon-Dschun Brauch, Hiltrud Brüning, Thomas Hamann, Ute Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title | Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title_full | Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title_fullStr | Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title_full_unstemmed | Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title_short | Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
title_sort | epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596937/ https://www.ncbi.nlm.nih.gov/pubmed/34789319 http://dx.doi.org/10.1186/s13148-021-01196-1 |
work_keys_str_mv | AT manoochehrimehdi epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT hielscherthomas epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT borhaninasim epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT gerhauserclarissa epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT fletcherolivia epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT swerdlowanthonyj epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT koyondschun epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT brauchhiltrud epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT bruningthomas epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients AT hamannute epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients |